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Abstract
Background: Adult-derived bone marrow stem cells are capable of reconstituting the
haematopoietic system. However there is ongoing debate in the literature as to whether bone
marrow derived cells have the ability to populate other tissues and express tissue specific markers.
The airway has been an organ of major interest and was one of the first where this was
demonstrated. We have previously demonstrated that the mouse airway can be repopulated by
side population bone marrow transplanted cells. Here we investigate the frequency and phenotypic
nature of these bone marrow derived cells.
Methods: Female mice were engrafted with male whole bone marrow or side population (SP) cells
and subjected to detergent-induced damage after 3 months. Donor cells were identified by Y
chromosome fluorescence in situ hybridisation and their phenotype was assessed by
immunohistochemistry on the same sections. Slides were visualised by a combination of widefield
and deconvolved microscopy and whole cells were analysed on cytospin preparations.
Results: The frequencies of engraftment of male cells in the airway of mice that show this (9/10),
range from 1.0 – 1.6% with whole marrow and 0.6 – 1.5% with SP cells. Undamaged controls have
only between 0.1 and 0.2% male cells in the trachea. By widefield microscopy analysis we find 60.2%
(53/88) of male donor derived cells express cytokeratins as a marker of epithelial cells. These
results were reinforced using deconvolved microscopy and scored by two independent
investigators. In addition cytospin analysis of cells dissociated from the damaged trachea of
engrafted mice also reveals donor derived Y chromosome positive cells that are immunopositive
for cytokeratin. Using cytokeratin and the universal haematopoietic marker CD45
immunohistochemistry, we find the donor derived cells fall into four phenotypic classes. We do not
detect cytokeratin positive cells in whole bone marrow using cytokeratin immunostaining and we
do not detect any cytokeratin mRNA in SP or bone marrow samples by RT-PCR.
Conclusion: The appearance of bone marrow derived cells in the tracheal epithelium is enriched
by detergent-induced tissue damage and the majority of these cells express an epithelial marker.
The cytokeratin positive donor derived cells in the tracheal epithelium are not present in the
injected donor cells and must have acquired this novel phenotype in vivo.
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The potential of adult-derived bone marrow cells being
localised to the airway is an attractive, novel therapeutic
approach for pulmonary repair. Much scientific debate
has centred on the ability of bone marrow-derived cells to
engraft into non-haematopoietic tissues and assume an
epithelial phenotype. The airway has been demonstrated
to be repopulated by bone marrow transplanted
cells[1,2]. There have been reports of extremely high levels
of donor-derived cells[3,4] but subsequent reports from
the same groups have either reduced this figure[2] or
refuted their own claims[5]. Some of the confusions are
undoubtedly due to the necessity for a particular type of
damage (but this is not well characterised) and analysis
techniques[6].
Often the detection of donor bone marrow-derived cells
relies on the expression of a transgenic marker present
only in that population. However, we found in the airway
that expression of the β-galactosidase transgene (present in
the male Rosa 26 donor cells) was not apparent in cells
that could be determined as donor on the basis of Y chro-
mosome fluorescence in situ hybridisation (FISH). This
may be a result of donor gene inactivation, down-regula-
tion or elimination [7]. Thus experiments that rely on
donor contribution by virtue of transgene expression
could underestimate the number of cells[5,8]. The reverse
is also true, as the colorimetric β-galactosidase substrate 5-
bromo-4-chloro-3-indolyl-beta-D-galactopyranoside (X-
gal) in adult tissue can be subject to false positive staining.
Detection of cells coincident for an immunohistochemi-
cal signal using serial sections is subject to error. It has also
been questioned whether the use of conventional wide-
field microscopy on the same section is able to resolve
overlapping or juxtapositioned cells[8]. This could lead to
erroneous identification of single cells with co-localised
markers rather than two independent cells. The use of
confocal or deconvolution microscopy on the same sec-
tion allows discrimination of adjacent cells and a true
determination of colocalisation of markers.
The engraftment of bone marrow cells into another tissue
type has been described as transdifferentiation but recent
work has suggested that fusion may be a more likely
explanation. Bone marrow-derived cells in the liver and
kidney have been shown to have arisen as a consequence
of fusion [7,9-12]. However Harris et al found no evi-
dence of fusion in lung, skin and liver [5] while Brittan
[13] et al found no evidence in the epidermis.
We have previously demonstrated that bone marrow-
derived side population (SP) cells contribute to the respi-
ratory tract of mice following engraftment of the haemat-
opoietic system and tracheal damage [1]. Here we extend
this study to reveal that whole bone marrow donor cells
also contribute to the tracheal epithelium following dam-
age but without damage the number of donor cells is 10
fold less. In the four out of five animals transplanted with
SP cells that showed airway engraftment, we determine
which donor cells express a blood cell marker and which
express the epithelial cell marker cytokeratin. We use Y
chromosome FISH to identify donor-derived cells and
deconvolved imaging to confirm colocalisation of these
cells with the epithelial marker cytokeratin. We find that
the majority of donor-derived cells express cytokeratin,
and some of these also express the CD45 haematopoietic
marker. A proportion of cells are consistent with being
inflammatory cells in that they only express CD45. Some
cells express neither haematopoietic nor epithelial cell
markers. We demonstrate that the donor cell population
does not express cytokeratin prior to injection and so the
cells in the epithelium have acquired a novel phenotype
in vivo.
Materials and methods
Mouse strains
Male ROSA26 mice of 6–10 weeks of age and backcrossed
for 5 generations to CBA/Ca, were bred in house and used
to isolate bone marrow. CBA/Ca female mice aged 8–12
weeks obtained from Charles River UK Ltd (England, UK)
were used as bone marrow recipients.
Bone marrow preparation
Bone marrow was extracted from the femurs and tibias of
mice and a single cell suspension prepared by passing the
bone marrow through a 21-gauge needle after which the
cells were pelleted by centrifugation and resuspended at
106 cells/ml in DMEM that contained 2% fetal calf serum
(FCS) and 10 mM Hepes (Gibco-BRL, Paisley, UK).
SP cell isolation
SP cells were isolated from the bone marrow according to
published methods [14]. Briefly, bone marrow was resus-
pended at 106 cells/ml in prewarmed DMEM as outlined
above. Hoechst 33342 (Bis-Benzimide) (Sigma Aldrich,
Dorset, UK) was added to the cells at a final concentration
of 5 μg/ml and the cells incubated at 37°C for 90 minutes.
After this time, the cells were pelleted and resuspended in
ice cold HBSS containing 2% FCS and 10 mM Hepes
(Gibco-BRL, Paisley, UK) and maintained at 4°C for anal-
ysis by flow cytometry.
Tracheal cell isolation
Tracheas were collected into PBS and digested for 1 hour
at 37°C in Ca2+, Mg2+ free media containing 1.4 mg/ml
Pronase (Roche, Lewes, UK) and 0.1 mg/ml Dnase1
(Sigma, Poole, UK). FCS was added to halt the reaction
and the husks washed twice with 2% FCS in PBS then dis-
carded. Cells were pelleted and resuspended at 105 cells/Page 2 of 14
(page number not for citation purposes)
Respiratory Research 2006, 7:145 http://respiratory-research.com/content/7/1/145ml in 2% FCS in PBS. For cytospin preparation cells were
then applied to slides by centrifugation at 104 cells/slide
using a Thermo-Shandon Cytospin4 (Pittsburgh, PA) at
800 rpm for 7 minutes. They were then fixed for 10 min-
utes in 4% paraformaldehyde (Sigma, Poole, UK) at room
temperature, washed twice in PBS for 5 minutes each, and
air dried before storage at -80°C.
Flow cytometry
Analysis and sorting was performed using a FACSVantage,
equipped with a Coherent INNOVA Enterprise II laser
(Becton and Dickinson, Oxford, UK) and performed as
originally described[14]. Briefly, the Hoechst dye was
excited at 350 nm and its fluorescence emission was col-
lected with a 424/44 band pass (BP) filter (Hoechst blue)
and a 675/20 BP filter (Hoechst red). A 610 SP was used
to separate the blue and red emissions. Propidium Iodide
(PI) (Sigma Aldrich, Dorset, UK) was added to the cells
prior to sorting at a final concentration of 2 μg/ml to dis-
tinguish and exclude dead cells in the bone marrow pop-
ulation. Sort gates were set as defined by Goodell[14].
After acquiring 1 × 105 live cells, the SP gate could be
clearly defined. The SP cells were then sorted into poly-
propylene tubes (BD Labware Europe, Combourg,
France) containing 100% FCS and an aliquot re-analysed
to check cell sort purity.
Irradiation and cell infusion
CBA/Ca female mice (8–12 weeks) were lethally irradi-
ated with 1050 rads delivered from a GammaCell 40E
(MDS Nordian, Fleuvus, Belgium) with a Cesium 137
source at a dose-rate of 114 Rads/minute. Following irra-
diation they received a single tail-vein infusion of 1 × 104
bone marrow-derived SP cells. In experiments where
whole bone marrow was used 1 × 107 cells were injected.
The animals were housed under specific pathogen free
(SPF) conditions in IVCs for 3 months. If the tracheas
were damaged, this was done by instillation with 10 μl 2%
polidocanol (Sigma, Poole, UK) (SP 1–5) or polidocinol
plus 1 mg/ml E.coli lipoplysaccharide (Sigma Poole, UK)
applied intranasally on day 2. All animals were harvested
7 days after the polydocinol instillation.
Experimental protocols involving animals were carried
out in accordance with permits and guidelines issued by
the MRC Ethical Review Committee and the United King-
dom Home Office.
Immunohistochemistry and histology of sections
Tracheas were removed from the appropriate animals and
fixed in 4% paraformaldehyde (PFA), processed to paraf-
fin wax blocks and cut to 7 μM sections by microtome.
Sections were then deparaffinised in xylene and hydrated
through an alcohol series before mounting for viewing,
carrying out immunostaining or for FISH analysis.
CD45 staining was performed before FISH. Slides were
dewaxed by washing 3 times in xylene for 5 minutes
before rehydration through an ethanol series (100%,
90%, 70%, 50%, 30%) and then placed into water. The
slides were then microwaved for 20 minutes in 0.1 M cit-
rate buffer ph 6.0. Slides were rinsed in PBS and then
blocked with 10% goat serum (Sigma, Poole, UK) for 1
hour at RT after which time the slides were washed in 3
times in PBS. The slides were incubated with rat anti-
mouse CD45 antibody (1 in 10) (BD Pharmingen,
Oxford, UK) overnight at 4°C. The slides were washed as
before and then incubated with CY3 labelled goat anti rat
secondary antibody (1:50) (Jackson ImmunoResearch
Laboratories, USA) for 2 hours at RT then washed and
mounted with Vectashield (Vector Laboratories, Peterbor-
ough UK) containing 1 μg/ml 4,6-diaminidino-2-phe-
nylindole (DAPI) counterstain.
Cytokeratin staining was performed after FISH. Slides
were blocked with 1% IgG (Sigma, Poole, UK) diluted in
5% donkey serum (Sigma, Poole, UK) for 20 minutes at
RT, washed 3 times in PBS and then blocked again in 5%
donkey serum, 2% BSA in PBST (0.1% Tween in PBS) for
30 minutes at RT. The slides were washed as before and
incubated with mouse pan cytokeratin ascites fluid
(Sigma, Poole, UK) (1:20) overnight at 4°C. The slides
were washed and then incubated with FITC labelled don-
key anti-mouse F(ab) fragment (1:50) (Jackson Immu-
noResearch Laboratories, USA) secondary antibody for 2
hours at RT then washed and mounted with Vectashield
containing 1 μg/ml DAPI. Negative controls using irrele-
vant isotype antibodies or missing out the primary anti-
body were carried out in parallel with every experiment.
Spleen was used as a positive control for CD45 as detailed
on IHC World online information center for immunohis-
tochemistry [15]. Sections were then stained with hema-
toxylin and metanil yellow according to standard
protocols.
Immunostaining of cytospun cells
Cytokeratin staining was performed before FISH. Briefly,
slides were washed three times in PBS, and then blocked
for 1 hour at RT in 10% goat serum (Sigma, Poole, UK).
The cytokeratin (1:1500) (DAKO Corporation, Carpinte-
ria, CA) antibody was then applied and the slides incu-
bated for 1 hour at RT. After this time they were washed
once in 0.1% Tween-20 in PBS for 5 minutes followed by
two washes in PBS. They were then incubated in the FITC-
conjugated cytokeratin secondary antibody (Jackson
ImmunoResearch Laboratories, Peterborogh, UK) for 1
hour at RT. The slides were then washed as above before
mounting in Vectashield containing 1 μg/ml DAPI. Cyt-
ospins were stained with hematoxylin and eosin (H and
E) according to a standard procedure.Page 3 of 14
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Slides were dewaxed and rehydrated as before. The slides
were then microwaved for 20 minutes in 0.1 M citrate
buffer ph 6.0 after which time they were denatured for 3
minutes in 70% formamide/2 × SSC, plunged into ice
cold 70% ethanol and dehydrated through an alcohol
series and air-dried.
Y chromosome FISH was carried out using a biotinylated
whole chromosome Y paint (Cambio, Cambridge, UK)
according to the manufacturers instructions. Briefly, the
probe was hybridised to the section overnight at 37°C.
Slides were then washed 4 times for 3 minutes in 2 × SSC
at 45°C then incubated for 30 minutes at 37°C with avi-
din Texas Red (Vector Laboratories, Peterborough UK).
This was followed by washing 3 times for 2 minutes in 4
× SSC, 0.1% Tween20 at 37°C after which time bioti-
nylated anti avidin (Vector Laboratories, Peterborough
UK) was added and the slides incubated further for 30
minutes. The slides were then washed as above and avidin
Texas Red added to the slides for a further 30 minutes
incubation at 37°C. After washing the slides as before,
they were mounted in Vectashield containing 1 μg/ml
DAPI. Male sections were taken through as positive con-
trols and female sections as negatives. Perinuclear nuclear
signals consistent with the Y chromosome were only
observed on the male sections and never on the female
slides.
FISH analysis for cytospins
FISH was carried out as above with the omission of the
dewax/rehydration step. Microwave incubation in citrate
buffer was for 30 minutes. 93% of tracheal cells from con-
trol male mice were positive (930 of 1000 cells counted)
and 0.1% of cells from female mice (1 cell in 1000 cells
counted) gave a false positive signal.
RNA extraction and PCR
Total ribonucleic acid (RNA) was extracted from cells
using the method of Chomczynski and Sacchi [16]. Cell
pellets were suspended in 1 ml of RNAzol (Biogenesis,
Dorset, U.K.) and placed in a 2 ml RNAse free tube
(Sarstedt, Leicester, U.K.) into which 1/10th volume of
chloroform was added. The solution was vortexed and left
on ice for 5 mins. The solution was then centrifuged at
10,000 rpm for 15 mins and the upper aqueous layer
removed into a fresh tube and an equal volume of ice-cold
isopropanol added. The solution was mixed and left at -
20°C for 30 mins. The RNA was then precipitated by cen-
trifugation at 10,000 g for 20 mins. The resulting RNA pel-
let was washed twice with 75% ice cold ethanol (2 × 5
mins 10,000 rpm spins) and resuspended in 20–100 μl of
RNAse free water and the concentration and purity of the
RNA determined by spectrophotometry (GeneQuant II,
Pharmacia Biotechnology, St Albans, U.K.).
Preparation of cDNA
Complementary DNA (cDNA) was made by the process of
reverse transcription using a cDNA synthesis kit (Roche
Applied Science). Briefly, 1 μg of RNA in a volume of 8.2
μl was reverse transcribed by mixing with the following
components, 2 μl oligo dT primer (0.8 μg/μl), 2 μl reac-
tion buffer (x10), 2 μl dNTP mix (40 mM), 4 μl 25 mM
MgCl2, 1 μl RNase Inhibitor (50U/μl) and 0.8 μl reverse
transcriptase (200u/μl). The reaction was carried out at
25°C for 10 mins and then at 42°C for 60 mins. The tube
was then placed at 95°C for 5 mins after which time the
cDNA was used for PCR.
Polymerase chain reaction
Following RNA extraction, cDNAs were prepared from
105 bone marrow cells or SP cells or non-SP FACS cells or
tracheal cells prepared from adult mouse trachea by diges-
tion as previously described and subjected to PCR[17].
cDNAs were amplified using sequence specific mouse
primers. Sequences of the primer pairs were as follows (all
written 5'-3' with forward primer first): Actin (Product size
450 bp) GGCCCAGAGCAAGAGAGGTATCC and ACG-
CACGATTTCCCTCTCAGC; CD45 (Product size 194 bp)
CCTGCTCCTCAAACTTCGAC and GACACCTCTGCT-
GCCTTAGC; Cytokeratin 19 (Product size 316 bp)
AAGACCATCGAGGACTTGC and AATCCACCTC-
CACACTGACC. The primers were used at a final concen-
tration of 1 μM each in the PCR reaction, which were
carried out under standard conditions. The thermal
cycling protocol for actin and CD45 comprised an initial
denaturation step at 94°C for 4 minutes followed by 43
cycles of 94°C for 1 minute, 60°C for 1 minute and 72°C
for 1 minute. The final cycle consisted of a re-annealing at
72°C for 10 minutes. A similar protocol was used for
cytokeratin 19 amplification except that the annealing
temperature was 57°C for 45 seconds. PCR products were
visualised on ethidium bromide stained 2% agarose gels
using a Herolab Easy RH-3 system (Scotlab, Coatbridge,
UK).
Image analysis
Slides were visualised using a Zeiss Axioplan 2 microscope
(Carl Zeiss UK, Welwyn Garden City, UK) equipped with
a Ludl filter wheel (Ludl Electronic Products, Hawthorne,
NY) and Chroma 83000 triple bandpass filter set
(Chroma Technology Corp., Rockingham, VT). Grayscale
images were collected with a Coolsnap HQ cooled CCD
camera (Roper Scientific, Tucsan, AZ). In-house scripts
written for IPLab (Scanalytics Corp.,Fairfax VA) were
employed for image capture and image processing. Slides
were also visualised using an Olympus 1 × 71 microscope
equipped with a ×60 lens. Images were captured using 0.2
μM optical sections and captured using DeltaVision Soft-
Worx software set at Bin 1 × 1. Further analysis was per-
formed using Imaris software.Page 4 of 14
(page number not for citation purposes)
Respiratory Research 2006, 7:145 http://respiratory-research.com/content/7/1/145Results
Donor cell engraftment in the bone marrow
Female mice were subjected to lethal irradiation and res-
cued by intravenous delivery of either 1 × 104 SP cells iso-
lated from male ROSA26 bone marrow or with whole
marrow (1 × 107 cells). SP cells are a subset (~0.1%) of
bone marrow cells that can be isolated by their ability to
exclude the DNA-binding dye Hoescht 33342[14]. They
are potent haematopoietic stem cells and even a single SP
cell is capable of reconstituting the haematopoietic sys-
tem[14,18]. Three months after the irradiation, the ani-
mals were subjected to detergent-induced epithelial cell
stripping of the trachea and sacrificed one week later.
Control transplanted animals not subjected to epithelial
stripping were also analysed. The level of haematopietic
engraftement in these mice was assessed by incubation of
the marrow at sacrifice with the non-fluorescent substrate
fluorescein Di-(β-D-galactopyranoside) (FDG). Donor
cells from Rosa26 mice ubiquitously express the β-galac-
tosidase gene product and so will convert FDG to a fluo-
rescent product which allows FACS analysis to be used to
determine the level of haematopoietic re-engraftment.
Animals given SP cells all displayed levels of haematopo-
etic re-engraftment in their marrow equal to or greater
than the control Rosa26[1]. Results for the whole bone
marrow transplantations are given in additional file 1:
FDG conversion by bone marrow and peripheral blood
cells from irradiated CBA and whole Rosa 26 bone mar-
row transplanted mice after 3 months.
marrow reconstitution after 3 months. The percentage of
FDG converting cells in both the lymphoid and granulo-
cytic populations are given in both marrow and periph-
eral blood. Re-engraftment of the undamaged series CW1-
4 at 3 months was equivalent to that observed for the SP
transplanted animals [1] i.e. not significantly different
from the Rosa 26 control. Re-engraftment of the W1-5 was
between 40–50% of the Rosa 26 control in the marrow
but showed high level of FDG conversion in the periph-
eral blood fractions.
Donor cell engraftment in the tracheal epithelium
Y chromosome FISH was then used to determine the
number of Y chromosome positive (donor) cells present
in the tracheal epithelium of these animals. In sections
from female mice, no false positive signal is seen with the
Y probe. Only 87% of male trachea probed using this pro-
tocol show a positive FISH signal in the nucleus and this
under-representation is probably due to the chromosome
being lost in the sectioning. We do not correct for this
underestimation of male positive cells. In the whole mar-
row transplanted animals, where there is no tracheal dam-
age (CW1-4) we see no significant donor-cell contribution
to the epithelial layer (table 1). Only 0.14% of cells (+/-
0.002) give a Y chromosome FISH positive signal. In the
whole marrow transplanted animals, where there is tra-
cheal damage (W1–W5), there is evidence of donor cells
in all of the treated mice, mean of 1.25 % of cells (+/-
0.06) in the epithelial layer of the trachea following dam-
age. This is significantly different to the untreated controls
(p > 0.01) and not significantly different to the numbers
seen for the SP experiment. Sections from the trachea of
the SP mice previously reported, revealed 4 out of the 5
mice had Y chromosome positive cells[1]. We have
extended the analysis previously done on the SP engrafted
mice from 8,056 total cells counted to 35,363 and the
number of cells positive for the Y chromosome in the four
positive animals remains around 1% (0.94% +/-0.39).
Table 1 reveals the spread of Y chromosome positive cells
in all the five animals subjected to analysis. Animal SP2
has no Y chromosome positive cells detectable in the cells
lining the trachea. This is most likely because the deter-
gent delivery was less successful than in the other animals.
The Y chromosome FISH was repeated three times on sec-
tions from this animal and each time this no male cells
were observed. The level of re-engraftment to the bone
marrow of SP2 was similar to the other animals and
equivalent to the Rosa26 control [1]. The level of engraft-
ment in the trachea in the positive animals SP1,3,4,5, var-
ied from 0.58% to 1.49%. Overall 350 positive cells were
scored out of 34,082 DAPI stained cells in these animals
(table 1).
Phenotype of donor-derived cells
CD45 status and widefield counts
Cells had previously been identified that were of male ori-
gin and were positive for the epithelial marker pan cytok-
eratin[1]. This mixture of antibodies recognises
cytokeratins 1,4,5,6,8,10,13,18 and 19 and is positive on
simple, cornifying and non-cornifying squamous epithe-
lia and pseudostratified epithelia[19]. We wished to fur-
ther characterise the donor cell contribution so we used a
protocol that allowed detection of CD45 (the universal
blood cell marker) and cytokeratin on the same slide. The
CD45 antibody used reacts with both alloantigens and all
isoforms of the CD45 leukocyte common antigen. Sec-
tions from the trachea were exposed to the antibody pro-
tocol described in materials and methods. Figure 1A(i,iii)
illustrates CD45 positive cells that reside in the epithelial
layer that lines the trachea. These positive cells were
marked and the sections then subjected to Y chromosome
FISH and immuno-staining for cytokeratin. The CD45 sig-
nal was lost when the sections were subjected to the FISH
protocol but the stored images could be found again and
compared against the FISH and cytokeratin staining. Fig-
ure 1A(i) reveals that some cells are CD45 positive and
both Y chromosome and cytokeratin positive (Figure
1Aii). Some are CD45 positive (Figure 1Aiii) and cytoker-
atin negative (Figure 1Aiv). The numbers of cells that were
Y FISH positive and either positive or negative for CD45Page 5 of 14
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(40.9%) of the donor-derived cells are cytokeratin posi-
tive and CD45 negative (see Table 2 and Figure
1A(v,vi,vii,viii)). However 19.3% (Table 2) of cells are
positive for both antibodies (eg. Figure 1A(i,ii)) It seems
likely that these cells have arisen from cell fusion as
detailed in kidney and liver [11] but could be due to
transdifferentiation and loss of the CD45 signal. The
15.9% (Table 2) of CD45 positive, cytokeratin negative
cells (eg. Fig 1Aiii,iv) are in keeping with an inflammatory
cell phenotype and therefore unremarkable. Figure 1A(ix
and x) show arrowed cells that are CD45 and cytokeratin
negative and represent the 23.9% of cells observed with
this phenotype (Table 2).
Overall by this analysis 60.2% (54/88 cells) of the donor-
derived cells residing in the tracheal epithelium were
cytokeratin positive.
Deconvolution microscopy for cytokeratin 
immunohistochemistry and Y chromosome FISH
Sections that had undergone Y chromosome FISH and
cytokeratin antibody treatment were subjected to analysis
using deconvolved microscopy to further confirm their
colocalisation. 205 cells out of 22271 were scored as Y
positive (0.92%). Two investigators scored cells inde-
pendently and then detailed analysis was undertaken on
125 Y chromosome positive cells (see Table 3). Of these,
101 were assigned a definite identity and 64 were scored
cytokeratin positive (63.4%) and 37 cytokeratin negative
(36.6%) by both investigators (Table 3). The remaining
cells did not receive a definite identity by both investiga-
tors so were excluded. These numbers are not significantly
different from the number of cytokeratin positive and
negative cells analysed by widefield microscopy (60.2%
and 39.8% respectively).
Figure 2 shows a series of images that demonstrate den-
convolved images of Y positive FISH cells and cytokeratin
stained sections. A-D are positive for cytokeratin and E
and F are negative. Movies of Y chromosome FISH posi-
tive cells that are either positive (additional file 2) or neg-
ative (additional file 3) for cytokeratin in additional files.
Cytospin analysis
The colocalisation of Y chromosome FISH positivity and
cytokeratin immunosignal was further confirmed by tak-
ing tracheal cell preparations from the 3 month engrafted
whole marrow transplanted mice. Following damage all
the 5 animals (W1-5) tested showed evidence of Y positive
cells by FISH carried out on the cytospin preparations and
Figure 3 clearly shows examples of cells that are Y FISH
positive and either cytokeratin negative (panels A, G and
I) or cytokeratin positive (panel B, C and E). Following H
and E staining, it would appear that the donor cell visible
in panels G and I is a macrophage (panel J).
Cytokeratin expression in the SPcells
We wished to eliminate the possibility that the donor-
derived cytokeratin positive cells present in the tracheal
epithelium had been present in the cells prior to injection
into the animals. RT-PCR was carried out on RNA
extracted from equal numbers of tracheal cells, whole
bone marrow, SP cells and non-SP marrow population to
see if we could detect any cells that expressed cytokeratin
19. No cytokeratin signal was detected in total bone mar-
row cells or in the SP or non-SP sorted cells, although a
robust signal was evident in the tracheal sample (figure 4).
This assay is sensitive to 1 in 2000 (Fig 4 lower panel) by
Table 1: Contribution of Y chromosome bone marrow SP cells to female recipient tracheas.
Mouse Y Chromosome +'ve Total DAPI Nuclei % Y Chromosome +'ve
CW1 2 2065 0.09
CW2 3 1738 0.17
CW3 2 1818 0.11
CW4 4 2098 0.19
W1 24 2356 1.02
W2 41 3777 1.09
W3 24 2165 1.11
W4 40 2788 1.43
W5 46 2885 1.59
SP1 186 12509 1.49
SP2 0 1281 0
SP3 41 7092 0.58
SP4 80 9660 0.83
SP5 42 4821 0.87
The number of Y chromosome positive cells in the tracheal epithelial lining of female mice irradiated and transplanted with male whole bone 
marrow (W1-5 and CW1-4) or SP cells (SP1-5) after 3 months. CW1-4 were undamaged animals, and SP1-5 and W1-5 were 1 week post 
polidocanol damage. Cells are scored by Y chromosome FISH and the number of cells counted using DAPI staining of nuclei.Page 6 of 14
(page number not for citation purposes)
Respiratory Research 2006, 7:145 http://respiratory-research.com/content/7/1/145
Page 7 of 14
(page number not for citation purposes)
Widefield visualisation of Y positive donor-derived cells and expression of CD45 and cytokeratin fall into four classesFigure 1
Widefield visualisation of Y positive donor-derived cells and expression of CD45 and cytokeratin fall into four 
classes. CD45 positive stained cells (CY3-red) were identified on tracheal sections, photographed, and their positions 
recorded. The CD45 signal was lost in subsequent manipulations. Sections were then subjected to Y chromosome FISH (Tx-
Red) and immunohistochemistry for cytokeratin (FITC-green). Donor-derived (Y FISH positive) cells fell into four classes 
(Table 2). Figure 1A shows a CD45 positive (i) and cytokeratin positive (ii) coincident cell arrowed; CD45 positive (iii) and 
cytokeratin negative (iv) coincident cell arrowed; CD45 negative (not shown) and cytokeratin positive (v,vi,vii,viii); CD45 nega-
tive (not shown) and cytokeratin negative (ix, x) arrowed cells. ix also contains a cytokeratin positive cell marked with an 
arrowhead. 1B top panel shows two CD45 positive (i) and cytokeratin positive (ii) cells and the brightfield staining of this tra-
cheal section (iii) with cells marked with arrows; Figure 1B bottom panel shows a CD45 positive (iv), cytokeratin negative (v) 
cell and photomicrograph (vi) shows brightfield staining of the same region with the cell marked with arrowhead. Additional file 
4 shows cytokeratin staining alone of tracheal sections and also cytokeratin staining after Y chromosome FISH illustrating that 
the distribution of cytokeratin staining is the same. Scale bar 5 uM.
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internal oligonucleotide (data not shown). We also
stained whole bone marrow cytospins with a pan cytoker-
atin antibody and could not observe any cells that were
positive (0/1546-data not shown).
We conclude that the cells in the trachea are unlikely to
have arisen by trapping in the airway following intrave-
nous delivery.
Discussion
There is ongoing debate in the literature as to whether
bone marrow cells have the ability to populate tissues and
express tissue specific markers. The airway has been an
organ of major interest and was one of the first where this
was demonstrated [20]. The fact that cells can repopulate
from a bone marrow source has been strongly debated but
irrefutable evidence of the ability of bone marrow cells to
acquire functional characteristics of tissue specific epithe-
lia has been generated using the fumarylacetoacetate
hydrolase (FAH) deficient mouse. This mouse exhibits
both liver injury and renal Fanconi syndrome when the
mice are not maintained on the drug 2-(2-nitro-4-trif-
luoro-methylbenzyol)-1,3 cyclohexanedione (NTBC).
Seven months after irradiation and bone marrow reconsti-
tution with genetically marked fah wild type haematopoi-
etic stem cells, robust donor cell contribution to the liver
was observed. These fairly rare events (50–200 distinct
donor cell-derived nodules) had undergone clonal expan-
sion to achieve oligoclonal repopulation of about 30–
50% of the liver mass. Thus the low engraftment efficiency
was enriched by selective outgrowth of the healthy cells.
Recently Held et al have reported that transplanted bone
marrow cells can replace up to 50% of the proximal tubu-
lar epithelium[11]. However, once again the high level of
repopulation required chronic and not acute injury and
genetic selection.
Thus functional reconstitution can happen, but without
the correct damage and selection it is a very inefficient
process. Our data here supports this conclusion with air-
way repopulation observed only after detergent-induced
damage. The damage agent used here was a detergent that
strips the epithelial lining from the basement membrane.
Following this treatment, no epithelial cells could be seen
by histology[21] but basal cells may remain as described
recently with naphthalene damage [22]. The mice are left
for a week following the damage. This acute damage
sequesters an inflammatory cell influx, which is largely
resolved and a neo-epithelium is established by 7 days [1].
Our results show that using Y chromosome to detect
donor-derived cells, between 0.6 and 1.5% of the epithe-
lium is donor-derived in transplanted mice following
damage. This level is comparable to the level reported for
the distal lung[2]. We see 60% (table 2) of the donor-
derived cells express cytokeratin. Cytokeratin is used as an
epithelial marker and the tracheal epithelial cells are
strongly positive for this marker. We do not detect any
cytokeratin signal in bone marrow or SP cells by RT-PCR
and so conclude that this must have been acquired in vivo.
CD45 is a universal blood cell marker and is strongly pos-
itive on the SP cells we use for transplantation[14]. 32%
of the cytokeratin positive donor-derived cells express
both CD45 and cytokeratin. This could be due to fusion
or transdifferentiation. The cells that are CD45 negative
but cytokeratin positive have lost the CD45 marker which
is expressed on all bone marrow-derived haematopoietic
cells. Hepatocytes that have arisen from fusion with bone
marrow-derived cells do not express CD45[7]. Harris et al
Table 2: CD45 and cytokeratin expression of the Y chromosome positive cells found in the mouse trachea.
Cell phenotype Number of cells % of total Y+ Cells
CD45+, Y+, Cytokeratin+ 17 out of 88 19.32%
CD45-, Y+, Cytokeratin+ 36 out of 88 40.91%
CD45+, Y+, Cytokeratin- 14 out of 88 15.91%
CD45-, Y+, Cytokeratin- 21 out of 88 23.86%
Numbers of cells positive for Y FISH, and/or CD45 and/or cytokeratin by immunohistochemistry in the tracheas of SP cell engrafted mice three 
months after irradiation and one week after detergent-induced damage.
Table 3: Contribution of Y chromosome bone marrow SP cells to female recipient tracheas assessed by deconvolution microscopy.
Number of positive cells % cells
Y positive cells counted 125 100
Cells analysed 101
Y FISH +ve cytokeratin +ve 64 63.4%
Y FISH +ve Cytokeratin -ve 37 36.6%
Numbers of cells analysed are those cells with a definite identity assigned independently by two investigators.Page 8 of 14
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type and they see no evidence for cell fusion in skin, liver
or lung in their assay[2]. As the test for fusion is depend-
ent on cre expression (which allows lox mediated excision
and expression of a reporter gene) it can be difficult to be
sure that a negative result is truly the absence of fusion
Deconvolved visualisation of cells with Y chromosome FISH and cytokeratin immunohistochemistryFigure 2
Deconvolved visualisation of cells with Y chromosome FISH and cytokeratin immunohistochemistry. Examples 
of Y chromosome positive cells by Y FISH (Tx-Red) and cytokeratin immunohistochemistry (FITC-green). Arrows mark cells 
positive for Y chromosome and either positive for cytokeratin (A,B,C,D) or negative (E and F). Videos of positive and negative 
cells can be found in additional files 2 (cytokeratin positive movie) and additional file 3 (cytokeratin negative movie).Page 9 of 14
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Co-localisation of Y FISH and cytokeratin immunosignal in single cellsFigure 3
Co-localisation of Y FISH and cytokeratin immunosignal in single cells. Female animals engrafted with male bone 
marrow were sacrificed after three months and cells dissociated from the tracheas were cytospun onto slides and subjected to 
Y FISH (red) and cytokeratin immunocytochemistry (green). Y positive (donor derived) cells are arrowed and both Y chromo-
some positive and cytokeratin negative (panels A,G and I) and Y positive, cytokeratin positive cells (panel B,C and E) were 
observed. Non-arrowed cells in panels A and B are cytokeratin positive but not Y FISH positive and presumably host female 
derived. Panels C and G show donor cells (arrow) stained for presence of Y chromosome and then the slides were counter-
stained with H and E (panel D and H respectively). Panels E and I show the donor Y FISH positive cells (arrowed) with panels F 
and J showing the same cells stained with H and E. The donor cell (arrowed) in panels I and J is cytokeratin negative and has 
macrophage morphology.
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Analysis of cytokeratin expression pattern in bone marrow and tracheal epithelial cellsFigure 4
Analysis of cytokeratin expression pattern in bone marrow and tracheal epithelial cells. Reverse transcriptase 
PCRs for actin, CD45 or cytokeratin (CK) were carried out on RNA extracted from various samples. Cells were dissociated 
from adult mouse trachea, adult bone marrow (BM), side population cells isolated from BM as described[1](SP), bone marrow 
from which the SP has been removed (-SP). Equal numbers of cells were used for the RNA extractions in each case. No cytok-
eratin signal was detectable in the SP cytokeratin RT-PCR. The lower panel shows cytokeratin RT-PCR on human bronchial 
epithelial (HBE) cell RNA and ROSA (Rosa 26 bone marrow cells) as positive and negative controls respectively. The dilution 
series (where the ratio of HBE to Rosa 26 marrow cells is varied) indicates that the cytokeratin signal can be amplified and vis-
ualised using ethidium bromide from an RNA sample extracted from 1 HBE cell seeded into 2000 ROSA bone marrow cells. 
Greater sensitivity is obtained by blotting and probing with an internal oligonucleotide (data not shown).
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male Rosa26 SP bone marrow cells as donors we see DNA
evidence of the Y chromosome and Rosa 26 targeted allele
in the tracheal epithelium of the female recipients, but we
do not see expression of the β-galactosidase transgene car-
ried by the Rosa26 mice[1]. This is unexpected as the
Rosa26 promoter clearly does drive expression normally
in the tracheal epithelia and other groups can use this
marker to detect bone marrow-derived cells [24-26].
Recently Chang et al and Kotton et al reported experi-
ments where they could not see any evidence of bone mar-
row cells reconstituting the lung epithelium following
bone marrow transplant[5,8]. The first study used donor
bone marrow cells expressing β-galactosidase either ubiq-
uitously or under control of a type II pneumocyte-specific
promoter. Using the cell type-specific promoter they saw
no reporter gene expression and with the ubiquitous pro-
moter the cells that appeared positive by widefield analy-
sis were not supported when the analysis was repeated
with deconvolution microscopy. Several aspects of our
work are different to their experiments. The two most
important being that we are studying the trachea rather
than the distal airway and that we induce damage and rep-
ithelialisation of the trachea where they do not. Our find-
ings are similar to those reported by other groups in that
we see no bone marrow-derived engraftment unless the
tissue is injured[6]. Chang et al rely entirely on radiation
(5Gy split dose) induced damage but we do not find the
level of irradiation we use (10.5 Gy single dose) to be suf-
ficient to promote engraftment without additional epithe-
lial damage. Additionally, Chang et al rely on expression
of a donor-derived transgene to identify engrafted cells
and yet (as mentioned previously) we have previously
reported that the ubiquitously expressed β-galactosidase
transgene is not a robust marker of transplanted cells in
the airway[1]. Consequently, we use FISH for the Y chro-
mosome as a marker of donor cells. We acknowledge their
consideration that it is a necessity to use dual deconvolved
microscopy and so we use this to confirm the co-localisa-
tion of Y FISH and cytokeratin expression.
The study by Kotton et al used whole bone marrow or SP
cells to engraft irradiated mice and use a bleomycin dam-
age protocol[5]. In contrast to their earlier reported work
with mesenchymal bone marrow-derived cells [4], they
see no evidence of engraftment in type II pneumocytes.
The same comments about the reporter are relevant here.
However this study used bleomycin as the damaging
agent. Bleomycin is known to induce fibrosis[27]. This
may mean that the type of donor bone marrow-derived
cells engrafted into the lung would not be pneumocytes
but fibroblasts[28]. These may be bone marrow-derived
but would not be marked by the surfactant protein C pro-
moter driven reporter Kotton et al use. Our use of the Y
chromosome is less sensitive to epigenetic effects that may
lead to shut down of gene expression. We show that
23.9% of donor-derived cells do not express CD45 or
cytokeratin. It is possible that these cells may have fused
with an endothelial or fibroblast cell and have subse-
quently lost their haematopoietic phenotype and CD45
expression.
Y chromsome FISH is a robust assay but may still under-
estimate the number of donor-derived cells. Our previous
work demonstrates that we loose 13% of positive cells in
male control 7 micron sections[1]. In addition Held et
al[11] describe FAH recipient male mice that are trans-
planted with female wild type bone marrow cells and
loose chromosomes from the donor cell. Cytospins of
kidney cells show cells that are FAH positive (donor-
derived) and yet have a normal recipient XY karyotype.
They suggest that following fusion a mitotic reduction
occurs, thus donor sex chromosomes are lost. If this
occurred in the airway we would not detect all donor cells
using Y FISH. The time between injury and sacrifice is
fairly low (7 days) in our experiments so there may not be
enough time for division and chromosome loss.
Rizvi et al recently reported evidence to suggest that bone
marrow-derived cells could fuse with intestinal stem
cells[29]. We only ever see isolated Y positive cells and so
we do not see clonal expansion implying that there has
been no involvement with a progenitor or somatic stem
cell.
The possibility of using autologous bone marrow cells for
genetic disease is an attractive prospect[30]. Combining
gene therapy and bone marrow cell engraftment would
bypass the need for immune suppression. The level of
bone marrow engraftment that we describe here is around
1%, which is unlikely to achieve clinical benefit for a
recessive disease such as cystic fibrosis. However, we have
previously demonstrated using mouse models that 5% of
normal levels of CFTR is sufficient to rescue the intestinal
phenotype apparent in these animals[31]. Recently two
groups have reported bone marrow transplantation of
cystic fibrosis mice with wild type cells. Loi et al used
naphthalene damage to injure the airway and saw only
rare (0.02%) donor-derived cells expressing an epithelial
marker[32]. The frequency of airway engraftment did not
alter with or without damage which contrasts with our
results and underlines the importance of the type of dam-
age. Bruscia et al only found very rare cells that were
donor-derived in both airway and gut[33]. They did not
damage the tissue but the CF mouse gut is subject to con-
tinuous inflammation. This group also found very low
levels of engraftment in both tissues (10-5) but could
detect wild type CFTR mRNA. Surprisingly the bioelectric
profile of mice transplanted with wildtype bone marrowPage 12 of 14
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pared to those transplanted with bone marrow from cystic
fibrosis mice. This implies that a very low level of cell ther-
apy gives an amplified electrophysiological effect. An
improvement above the very low level of engraftment
observed by these two groups may have significant clinical
impact. The improved level of engrafted donor cells
observed in our study indicates that the type of damage is
important and may lead to ways to manipulate cell ther-
apy to a clinically relevant level. Identifying what signals
induce efficient engraftment to the airway is essential to
the clinical relevance of this work.
Conclusion
This study demonstrates that following detergent-induced
damage the airway of the re-epithelialised trachea con-
tains cells derived from adult bone marrow cells. These
donor bone marrow-derived cells are present in the epi-
thelia at a frequency of around 1% and fall into four phe-
notypic classes based on expression of the epithelial
marker cytokeratin and the universal blood cell marker
CD45. The majority of cells express cytokeratin either with
or without CD45. The transplant donor cells do not
express cytokeratin so this novel phenotype must have
been acquired in vivo.
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